Medicare Enrolled
Dr. Philip Ames, M.D.
Ophthalmology · Bradenton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ames from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ames?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ames
Dr. Philip Ames is an ophthalmology specialist in Bradenton, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Ames performed 67,900 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ames received a total of $2,740 from 25 pharmaceutical and/or device companies across 91 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ames is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 1% volume in FL
$2,740 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 145786 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗67,900
Medicare services
Top 1% in FL for ophthalmology
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
55,620 | $29 | $40 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,767 | $28 | $50 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,957 | $88 | $185 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,591 | $82 | $150 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
1,440 | $119 | $160 |
| Aflibercept eye injection (Eylea) | 1,316 | $696 | $1,050 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
830 | $92 | $145 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $65 | $105 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
291 | $18 | $30 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
256 | $915 | $1,320 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
204 | $27 | $85 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
61 | $93 | $185 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
49 | $183 | $700 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $130 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $112 | $185 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
38 | $46 | $80 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
20 | $394 | $700 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
19 | $11 | $64 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
16 | $1 | $15 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
15 | $40 | $136 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
13 | $551 | $1,200 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
12 | $31 | $213 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$2,740
Total received (2018-2024)
Avg $391/year across 7 years
Top 40% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
91
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$974
2023
$447
2022
$219
2021
$343
2020
$86
2019
$369
2018
$303
Payments by company (2024)
Notal Vision, Inc.
$191
Regeneron Healthcare Solutions, Inc.
$163
ABBVIE INC.
$127
Astellas Pharma US Inc
$112
Genentech USA, Inc.
$98
Alimera Sciences, Inc.
$85
Bausch & Lomb Americas Inc.
$82
Apellis Pharmaceuticals, Inc.
$53
Harrow Eye, LLC
$40
Ocular Therapeutix, Inc.
$23
Top 3 companies account for 49.4% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$313
Notal Vision, Inc.
$265
Novartis Pharmaceuticals Corporation
$229
Regeneron Healthcare Solutions, Inc.
$217
ABBVIE INC.
$176
Apellis Pharmaceuticals, Inc.
$155
AbbVie Inc.
$149
Mallinckrodt Hospital Products Inc.
$148
Alcon Vision LLC
$136
Astellas Pharma US Inc
$134
Allergan Inc.
$119
Mallinckrodt Enterprises LLC
$117
Johnson & Johnson Surgical Vision, Inc.
$92
Second Sight Medical Products, Inc.
$91
Alimera Sciences, Inc.
$85
Bausch & Lomb Americas Inc.
$82
Glaukos Corporation
$57
Harrow Eye, LLC
$40
Carestream Health, Inc.
$29
Ocular Therapeutix, Inc.
$23
Sun Pharmaceutical Industries Inc.
$20
VYERA PHARMACEUTICALS, LLC
$17
Aerie Pharmaceuticals, Inc.
$17
Genentech, Inc.
$14
EyePoint Pharmaceuticals US, Inc.
$14
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · Argus II Retinal Prosthesis System · BEOVU · CARESTREAM DRX-1 System · Cequa · Constellation · DEXTENZA · DEXYCU · Daraprim · EYLEA HD · Foresee Home · IHEEZO · Izervay · LUMIGAN · Lucentis · MIEBO · OZURDEX · Rocklatan · Syfovre · Tecnis 1-piece IOL · VABYSMO · Vabysmo · XIPERE · YUTIQ · iStent inject Trabecular Micro-Bypass Stent System · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
77
County median income
$75,792
Nearest hospital to ZIP centroid (approximate)
MANATEE MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ames is a mixed practice specialist, with above-average Medicare volume (top 1% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ames experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Ames performed 55,620 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ames receive payments from pharmaceutical companies?
Yes. Dr. Ames received a total of $2,740 from 25 companies across 91 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ames's costs compare to other ophthalmologists in Bradenton?
Dr. Ames's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ames) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Bradenton
Browse ophthalmologists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Notal Vision, Inc. Payments to Doctors
See all physicians who received payments from Notal Vision, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology